ArticleJournal of addiction medicine2025
Veterans Health System Leader and Clinician Perspectives on Expanding Access to Methadone Treatment for Opioid Use Disorder.
Article in Journal of addiction medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesPrivate methadone treatment paid for by the Department of Veterans Affairs (VA), called community care (CC), and mobile opioid treatment programs (OTPs) are strategies to expand Veteran access to methadone treatment for opioid use disorder. The purpose of this evaluation was to investigate leader and clinician perspectives on these modalities compared with treatment provided directly by VA OTPs.
methodsSemi-structured interviews were conducted with VA OTP leaders and clinicians from 12 of the 33 VA OTP sites nationwide. Participants (N=24) were asked to compare access, quality, and cost of methadone treatment between VA OTPs and CC and asked about the feasibility of deploying mobile OTP services. Two analysts independently coded the transcribed data and used thematic analysis to identify salient themes and representative quotes.
resultsVA leaders and clinicians perceived CC to have longer wait times and lower quality care, but expected these services to be less expensive than VA OTPs. Mobile OTP services were viewed as a potential solution to improve access, though concerns were raised about staffing and the reduced availability of wrap-around services. Key considerations for successful mobile OTP implementation included identifying high-need localities, addressing patient needs, and ensuring financial viability.
conclusionsWithin and outside VA, there is growing interest in expanding access to medications for OUD, such as methadone. Leaders and clinicians highlighted important access, quality, and cost considerations when exploring innovative treatment modalities for methadone, such as mobile OTP services and CC. Findings from this VA evaluation may guide methadone treatment improvement in other health systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.